Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer clinical trial (NCT00851084). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from aflibercept and modified FOLFOX6?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer clinical trial (NCT00851084). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer clinical trial (NCT00851084). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience severe side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer clinical trial (NCT00851084). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer clinical trial (NCT00851084). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements for attending treatment sessions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer clinical trial (NCT00851084). Contact the study team or your healthcare provider for specific answers.

What this study is about